US Drug Czar Voices Concerns to WADA on China Doping Allegations

The US drug czar, Rahul Gupta, has raised significant concerns with the World Anti-Doping Agency (WADA) regarding the handling of doping allegations against Chinese swimmers before the Tokyo Olympics in 2021. In a letter dated May 8, obtained by The Associated Press, Gupta, who also serves on WADA's executive committee, expressed the global apprehension surrounding the agency's response to these allegations.

Gupta's letter to WADA's president called for an urgent executive committee meeting to address these concerns promptly. In response, WADA has convened an "extraordinary session" of its foundation board, which possesses ultimate authority over the agency's policies, for Friday. Notably, this board does not include a US representative.

The controversy stems from allegations that 23 Chinese swimmers were exonerated from intentionally using performance-enhancing drugs, attributing the presence of a banned heart medication in their systems to contamination. The decision has faced criticism, prompting WADA to commission an independent investigation led by a Swiss lawyer—a move that has also drawn scrutiny.

Gupta criticized the lack of transparency and involvement in the decision-making process for launching the investigation. He highlighted that members of the executive committee representing governments were neither adequately briefed nor involved in a formal vote to initiate the probe.

Furthermore, Gupta's letter emphasized the need for greater clarity and transparency from WADA regarding several aspects of the case. He requested detailed information on WADA's knowledge timeline and rationale for not pursuing further actions like investigating the contamination claims or deriving lessons to enhance the anti-doping system.

The US Office of National Drug Control Policy, led by Gupta, plays a crucial role in funding WADA. The United States is set to contribute USD 3.6 million to WADA's 2024 budget of USD 50 million, making it the largest single contributor to the agency.

This situation underscores ongoing challenges within international sports governance and anti-doping efforts. The global community awaits further developments from WADA's forthcoming board session and any potential shifts in policy or investigative approaches that may result.